Twidale N, Roberts-Thomson P, McRitchie R J
Department of Medicine, Flinders Medical Centre, Australia.
Am Heart J. 1993 Jul;126(1):122-9. doi: 10.1016/s0002-8703(07)80018-4.
The effects of intravenous boluses of amiodarone (5 mg/kg), racemic sotalol (enantiomeric ratio d/l-sotalol 1:1;1.5 mg/kg), and d-sotalol (0.75 mg/kg) on mean arterial pressure (MAP), heart rate (HR), cardiac output (CO), total peripheral resistance (TPR), left ventricular end-diastolic pressure (LVEDP), and peak rate of change of left ventricular pressure (LV dp/dt) were assessed in conscious rabbits. Amiodarone and sotalol had a modest negative inotropic effect: amiodarone reduced peak LV dp/dt by 8 +/ 2% (mean +/- SEM) (p < 0.05) and sotalol by 6 +/- 2% (p < 0.05). These two drugs had quite different effects on CO as a result of differences in their actions on peripheral blood vessels: amiodarone caused a 13 +/- 3% (p < 0.05) increase in CO associated with a substantial vasodilatory effect (TPR reduced 25 +/- 3%; p < 0.01); sotalol did not produce any substantial change in either CO or TPR. Bolus intravenous injection of amiodarone was associated with a significant increase in HR (12 +/- 3%; p < 0.01), whereas sotalol reduced HR by 7 +/- 1% (p < 0.05). In contrast, administration of the dextro-rotatory optical isomer, d-sotalol, produced no significant change in peak LV dp/dt, LVEDP, CO, TPR, or HR. These results confirm that amiodarone and racemic sotalol have a comparatively weak cardiodepressant action. The experiments also show that the reduction in cardiac performance associated with racemic sotalol is mediated predominantly through the beta-adrenoreceptor blocking action of the levo-rotatory isomer (l-sotalol) rather than any substantial cardiodepressant effect of the dextro-rotatory isomer.
在清醒兔中评估了静脉注射大剂量胺碘酮(5mg/kg)、消旋索他洛尔(对映体比例d/l-索他洛尔为1:1;1.5mg/kg)和d-索他洛尔(0.75mg/kg)对平均动脉压(MAP)、心率(HR)、心输出量(CO)、总外周阻力(TPR)、左心室舒张末期压力(LVEDP)以及左心室压力变化率峰值(LV dp/dt)的影响。胺碘酮和索他洛尔具有适度的负性肌力作用:胺碘酮使LV dp/dt峰值降低8±2%(均值±标准误)(p<0.05),索他洛尔使LV dp/dt峰值降低6±2%(p<0.05)。由于这两种药物对外周血管作用不同,它们对CO的影响差异很大:胺碘酮使CO增加13±3%(p<0.05),伴有显著的血管舒张作用(TPR降低25±3%;p<0.01);索他洛尔对CO或TPR均未产生任何显著变化。静脉注射大剂量胺碘酮与HR显著增加相关(12±3%;p<0.01),而索他洛尔使HR降低7±1%(p<0.05)。相比之下,给予右旋光学异构体d-索他洛尔后,LV dp/dt峰值、LVEDP、CO、TPR或HR均未产生显著变化。这些结果证实胺碘酮和消旋索他洛尔具有相对较弱的心脏抑制作用。实验还表明,与消旋索他洛尔相关的心脏功能降低主要是通过左旋异构体(l-索他洛尔)的β-肾上腺素能受体阻断作用介导的,而非右旋异构体的任何显著心脏抑制作用。